The rationale for the medical malpractice liability system is to compensate patients injured due to negligent care and to deter providers from practicing negligently. Limited evidence is available regarding experience with medical malpractice in radiation oncology. We review characteristics and national trends in radiation oncology malpractice claims and their associated costs and compare radiation oncology claims to those of other specialties. This study provides evidence that can be used to improve patient safety, minimize risk, Purpose: The purpose of this study was to determine trends in radiation oncology malpractice claims and expenses during the last 28 years and to compare radiation oncology malpractice claims to those of other specialties. Methods and Materials: We performed a retrospective analysis of closed malpractice claims filed from 1985 to 2012, collected by a nationwide medical liability insurance trade association. We analyzed characteristics and trends among closed claims, indemnity payments (payments to plaintiff), and litigation expenses. We also compared radiation oncology malpractice claims to those of 21 other medical specialties. Time series dollar amounts were adjusted for inflation (2012 was the index year). Results: There were 1517 closed claims involving radiation oncology, of which 342 (22.5%) were paid. Average and median indemnity payments were $276,792 and $122,500, respectively, ranking fifth and eighth, respectively, among the 22 specialty groups. Linear regression modeling of time trends showed decreasing total numbers of claims (b Z À1.96 annually, PZ.003), increasing average litigation expenses paid (b Z þ$1472 annually, P .001), and no significant changes in average indemnity payments (b Z À$681, PZ.89). Conclusions: Medical professional liability claims filed against radiation oncologists are not common and have declined in recent years. However, indemnity payments in radiation oncology are large relative to those of many other specialties. In recent
Introduction
The rationale for the medical malpractice liability system is to compensate patients injured due to negligent care and deter providers from practicing negligently (1) . It is unclear whether this system improves patient safety and quality of care (2, 3) . Certainly, being sued for medical malpractice is a great concern to practicing physicians (4) . One study from a large liability insurer covering more than 40,000 physicians found that 7.4% of all physicians face a malpractice claim in any given year, with 1.6% facing a claim resulting in payment (5) .
Despite media attention to catastrophic medical errors in radiation oncology (6) (7) (8) (9) , there are very few systematic studies of malpractice claims in this specialty. Elliot et al (10) evaluated 13 cases involving prostate brachytherapy, where claims typically involved an alleged breach of standard of care. Another study reviewing 20 malpractice suits involving a single expert reviewer identified the most common allegation as delays in diagnosis, breach of standard of care, or failure to obtain a second opinion (11) . None of these studies reported the severity of claims or litigation expenses. Studies of malpractice claims filed against oncologists in lung cancer, head and neck cancers, skin cancer, and sarcoma (12) (13) (14) (15) (16) (17) have neglected implications for radiation oncology. Furthermore, these studies (12) (13) (14) (15) (16) (17) describe only cases that were formally adjudicated in court, representing only 8% of all filed malpractice claims (18) .
This study sought to determine trends in radiation oncology malpractice claims and expenses during the last 28 years. We also compared malpractice claims in radiation oncology to those in other specialties.
Methods and Materials
We performed a retrospective analysis of medical liability claims data from the Physician Insurers Association of America (PIAA) that identified a radiation oncologist as the primary defendant between January 1, 1985, and December 31, 2012. The PIAA is a nonprofit trade association representing medical professional liability insurance companies that insure more than two-thirds of private practice physicians in the United States (19) . The PIAA Data Sharing Project (DSP) is a database containing information for more than 278,000 closed medical liability claims from 25 participating companies, representing the largest independent database of medical liability claims with specialtyspecific data (19) .
Primary outcome variables were closed claims, paid claims, percentage of closed claims resulting in indemnity payment to the plaintiff, average indemnity payments, and average litigation expenses for each year of the study period and for the most recent 10-year period. A "claim" was defined as any written demand for monetary compensation by a patient or a patient's family stemming from an alleged injury during the patient's medical care by the insured clinician. A claim was "closed" when there was a resolution by settlement, by court verdict or arbitration, or when a claim was withdrawn, dropped, or dismissed without payment. Indemnity was defined as compensation "for loss or damage that has already occurred, or to guarantee through contractual agreement to repay another party for loss or damage that occurs in the future" (20) . Adjudicatory outcomes included whether the claim resulted in indemnity payment to the plaintiff ("paid claims") or ended without payment ("no indemnity") and the amount of indemnity payment ("severity"). Litigation expenses ("expenses"), also known as loss adjustment expenses, were also analyzed. These expenses are related to the defense of a liability claim, including expenses paid in the process of administering or adjudicating a claim (such as investigative costs, attorney fees, expert witness fees, court costs, and others) (19, 21) .
First, we compared demographics of the physicians who were sued to those of the national radiation oncology workforce. Demographic information about the involved radiation oncologist was obtained by PIAA when available and released by the insurer. Because PIAA does not report the number of insured physicians, we used annual workforce data as reported in the American Medical Association (AMA) physician master file (22) to estimate the number of active physicians in each specialty per year in the United States. National workforce data from calendar years 1987, 1990, 1994, and 2002 were not available in the AMA Physician Characteristics and Distribution publication; therefore, linear interpolation to impute data for the missing years was performed because demographic data were provided in aggregate and variability in physician workforce data for each specialty was expected to be constant (stationary) with time (23, 24) . Comparisons between demographics of sued radiation oncologists and those of the national radiation oncology workforce were performed using Pearson c 2 test for the entire study period as well as for 2003 to 2012 in order to evaluate recent demographic characteristics.
We then performed a cross-sectional comparison of closed claims during the study period for radiation oncology to those of 21 other medical specialties. Closed claims, paid claims, and average and median indemnity, and total indemnity were described for each specialty. Median indemnity payments were included when comparing specialties to represent the most common experience in each specialty due to outliers in the data (23) . We calculated an estimated proportion of active physicians represented in the PIAA DSP by specialty, as the number of active physicians varied considerably by medical specialty. This was done by dividing the number of claims by the cumulative number of active physicians per "physicianyear" during the period from AMA workforce data described above, representing the maximum proportion of physicians in each specialty that had a claim in the PIAA DSP. This exploratory analysis was a simple proportion and was not intended as a direct normalization or risk calculation, because inherent population differences between the PIAA and AMA datasets preclude the latter. Finally, we analyzed time trends of closed claims, paid claims, percentage of closed claims that were paid, average indemnity payments, and average litigation expenses for radiation oncology by using simple linear regression and log-linear regression. These values were reported as trends or annual changes (b) and average annual percent changes (exp(b) À 1) (25) . We also evaluated claims by associated personnel, defined as any associated professional that was named in the claim.
All tests were performed using an a value of .05 and 95% confidence intervals. Time series dollar amounts were adjusted for inflation by using the Consumer Price Index for all urban consumers for all items, with 2012 as the index year (26) . Statistical analyses were conducted using SPSS software, version 22.0 (IBM Corp., Armonk, NY).
Results
From 1985 to 2012, 1517 closed claims reported to the PIAA DSP involved radiation oncologists, of which 342 (22.5%) were paid. Table 1 compares demographics of sued radiation oncologists in the PIAA with those of active physicians in the AMA. Sued radiation oncologists were primarily in solo practice (72.2%) and were more likely to be middle aged (35-54 years of age; P<.001), compared with national workforce demographic data. The proportion of physicians sued previously was 71.9%, and 91.9% of sued physicians were board certified. However, these physicians represented only 41.5% and 51.0%, respectively, of sued physicians because only approximately 50% of claims reported these data. Sued radiation oncologists were more likely to be male (P<.001), and international medical graduates (IMGs; PZ.002). In the last 10 years, there were no differences between the proportion of IMGs sued and those in the national workforce (PZ.41), and a smaller proportion of sued physicians were in solo practice (52% vs 72%, respectively, for 1985-2012).
Radiation oncology had the fewest number of closed claims (<1%) among all reported specialties during the 28-year period (Table 2 ). Only 22.5% of closed claims resulted in indemnity payment, ranking radiation oncology 18th Values for radiation oncology are displayed in boldface. * Closed claims are medical liability claims that were resolved through settlement or verdict or were withdrawn, dropped, or dismissed without payment.
y Paid claims are medical liability claims that resulted in indemnity payment to the plaintiff as a result of settlement or court adjudication. z Percentage of closed claims paid refers to the percentage of all closed claims that were paid to the plaintiff as a result of settlement or court adjudication.
x Total indemnity is the sum of all indemnity payments during the period. k Average indemnity is the mean amount of award for paid claims during the period. The average indemnity payment per claim for radiation oncology was $276,972, ranking radiation oncology fifth of 22 specialties. The median indemnity payment was lower than the average indemnity payment for all specialties (Fig. 1) . Total payments for radiation oncology claims ($94,661,971) represented fewer than 1% of total payments ($17,895,699,524) for all specialties during the study period. The median indemnity payment for radiation oncology was $122,500, ranking radiation oncology eighth among 22 specialties. The specialties with the highest median indemnity were neurosurgery ($183,735) and neurology ($175,000); dermatology had the lowest median payment of only $35,000.
Estimates of the proportion of physicians in each specialty that had closed and paid claims in the PIAA DSP are presented in Table 3 . These estimates show that the maximum proportion of the radiation oncology workforce represented in the DSP was 2.4% for closed claims and 0.68% for paid claims. Table 4 shows the trends of radiation oncology closed claims, payments, and expenses from 1985 to 2012 and 2003 to 2012. The number of radiation oncology closed claims decreased over time (b Z À1.96 claims annually, PZ.003; À3.5% annually, respectively; PZ.003), the percent paid of closed claims increased (b Z 0.73% annually, PZ.006; þ2.8% annually, PZ.046), and average expenses paid increased (b Z $1472 annually, P .001; þ5.0% annually, P<.001). No significant trend was observed for the average indemnity paid (PZ.89) (Fig. 2a and 2b) . No significant trend was observed for total indemnity or expenses or total expenses for paid claims. Over the last 10 years (2003e2012), no significant trends were observed (Table 4) .
During the last 10 years, the 2 personnel most commonly named in closed claims included physicians (including radiologists, emergency medicine physicians, pathologists, and unspecificed "other" physicians; named 140 times) and therapists (named 7 times). Up to 3 associated personnel were reported for each record, so it is unclear how many individual claims reported associated personnel.
Discussion
The current study is the first comprehensive analysis of nationwide medical liability claims data for radiation oncology, spanning 28 years. When we compared sued radiation oncologists in the PIAA DSP to the national radiation oncology workforce, we found that a greater proportion of sued physicians were male and that only 5% to 6% of sued female physicians reported working part time, which is less than that in national estimates (17.5%) (27) . The larger proportion of males working full time might have influenced the sex of sued physicians; however, the changing sex demographics of the radiation oncology workforce likely played a larger role: a greater number of claims were closed early in the study period when men represented a greater proportion of the workforce (22) . Our data show that the proportion of claims attributable to IMGs has decreased, consistent with the proportion of IMGs in the radiation oncology workforce, which also decreased from 31% in 1985 to 14% in 2012. We also found that the proportion of solo practitioners was high among sued physicians compared with that of other practice types. Data from the American College of Radiology (ACR) survey between 1995 and 2003 show relatively stable numbers of solo practitioners (8%-11%) (27, 28) , and recent National Plan and Provider Enumeration System data (29) showed that 12.5% of 4503 individual radiation oncologists were sole proprietors. Our study found that the proportion of claims attributed to solo practitioners dropped from 72% overall to 52% for the last 10 years. Radiation oncology practice accreditation, obtained though ACRAmerican Society for Radiation Oncology (30), requiring peer review documentation, is one possible reason for reduction in claims by introducing increased quality assurance and peer review.
Radiation oncologyerelated liability claims represent fewer than 1% of all reported closed claims. We expected that this number would be <1% because radiation oncology physician-years during the study period also represent <1% of all physician-years for all specialties. Despite a growing physician workforce and patient population (31) over the study period, the number of closed claims has recently declined by approximately 2% per year, and the number of paid claims has also decreased, although this trend was not significant. Our findings are similar to, although to a lesser extent, recent reports from the National Practitioner Data Bank showing that the number of closed and paid claims dropped 34% and 38%, respectively, in the last 10 years (32). Previous authors have also found that payment amounts have not changed significantly in recent Values for radiation oncology are displayed in boldface. * Closed claims are medical liability claims that were resolved through settlement or verdict or were withdrawn, dropped or dismissed without payment.
y Paid claims are medical liability claims that resulted in indemnity payment to the plaintiff as a result of settlement or court adjudication. z Calculated using the number of active physicians for each specialty in 2012 obtained from AMA master file data (22) .
x Proportion of physicians with a closed or paid claim in the PIAA DSP is the number of closed or paid claims over the period divided by the number of physicians over the period in that specialty (physician-years), representing the maximum proportion of physicians in that specialty that have a claim in the DSP during the period. years (32, 33) . Indemnity payments in radiation oncology are large relative to many other specialties, although we also found that these payments have been stable over time.
A recent decrease in the volatility of insurance premiums has also been observed (34) . In addition to other market factors, increased expenses have historically been associated with rising premiums and decreased availability of malpractice insurance (35) . Although we do not report on insurance premiums, we found that litigation expenses for all radiation oncology closed claims continued to rise on average from 1985 to 2012 for both paid claims and claims with no indemnity, although they have stabilized in the last 10 years. The 2010 final report by the Centers for Medicare and Medicaid Services (CMS) (36) on malpractice relative value units by specialty reflects the relative costs to practitioners of professional liability insurance. This report ranked radiation oncology as having a greater nonsurgical risk than 32 of 37 nonsurgical specialties. For surgical risk, radiation oncology ranked 15th among 46 specialties. Our data are consistent with CMS estimates that radiation oncology has higher nonsurgical risk, which may lead to higher payments but less overall risk due to a lower risk factor associated with surgical procedures, thereby resulting in fewer claims (36) .
Recent PIAA DSP data for all physician specialties (18) showed physicians faced an 8% increase in expenses from 2003 to 2012 and that expenses increased at a rate of 2.5 times that of total indemnity payments. For our more recent data regarding total indemnity (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) , data by year were unavailable, so we were limited in our ability to comment on trends in indemnity payments without the possible influence of outliers. We also found that other physicians and technicians were the associated personnel most commonly named in claims. The involvement of associated personnel seems appropriate given the teambased environment in which radiation oncology is practiced, although we cannot comment on what types of claims involved other personnel due to the aggregate nature of the data.
Our study adds to the current research by providing a large systematic analysis of closed (paid and unpaid) malpractice claims in the United States. Most previous studies of oncology claims have evaluated jury verdicts (10, (12) (13) (14) (15) , which are limited to approximately 8% of closed claims (18) . A previous study of claims in lung cancer patients, also using PIAA data, does not provide specific information for radiation oncology (16) . National Practitioner Data Bank analyses do not include physician Significant P values are shown in boldface. * Trend over time was modeled with linear regression. y Trend over time was modeled with log-linear regression (25) . z Adjusted for inflation, using 2012 as the index year (26).
x Expenses are litigation expenses related to the defense of a liability claim, including expenses paid in the process of administering or adjudicating a claim.
specialty, sufficient data regarding the nature of claims, or information on claims that were not paid (21) and represent approximately 30% of all claims filed (21, 33) . Furthermore, PIAA DSP data, although not generalizable given the lack of exposure data, do represent a greater proportion of the physician workforce than studies based on single or small numbers of insurance firms. Our study has several limitations, many of which are inherent to the source data from the PIAA DSP. The most significant limitation is absence of exposure data. All information in the PIAA DSP database is reported on a per claim basis. They do not report the number of insured physicians in a given year, so it is not possible to directly calculate claims frequency per physician. We used AMA Masterfile data for active physicians by specialty to understand what percentage of the national workforce was represented as having a closed claim in the PIAA DSP, but these data do not generalize beyond the DSP. Similarly, we compared differences in demographic information among sued radiation oncologists to the national radiation oncology workforce, but again these comparisons are limited in their generalizability beyond the DSP, given the selection bias of the data that we are unable to evaluate. A second major limitation is that PIAA member companies have guidelines to ensure that there is consistency and uniformity in data collection and reporting, but there may certainly be errors in such a registry. However, McLean et al (16) analyzed PIAA coding used to aggregate data in the DSP and found only minor differences between the dataset and available case abstracts for malpractice litigation in the setting of lung cancer, suggesting the data for radiation therapy in the present study are likely to be representative of liability claims. Additionally, PIAA DSP aggregation of data without claim-specific or variance measures limits our ability to analyze and draw conclusions from the data presented. Still, the PIAA DSP database is the only national database that provides specialty-specific information on malpractice claims as well as information on closed claims that were not paid.
Conclusions
Our study demonstrates the need for additional, detailed analyses of the underlying causes of claims in radiation oncology to guide translation of these findings to risk reduction, preventing malpractice claims, and improving patient safety (37) . Malpractice continues to be a significant concern for physicians, policy makers, and patients alike, as the rapidly evolving health care environment and ongoing legal battles surrounding malpractice reform add uncertainty to the future. Although medical professional liability claims filed against radiation oncologists are not common and the annual number of closed claims has declined, litigation expenses have increased, and indemnity payments in radiation oncology are high relative to those of many other specialties. This evidence can inform efforts by physicians and national organizations interested in improving patient safety, decreasing costs of care, and minimizing risk.
